APA
Onuma Y., Serruys P. W., Muramatsu T., Nakatani S., van Geuns R., de Bruyne B., Dudek D., Christiansen E., Smits P. C., Chevalier B., McClean D., Koolen J., Windecker S., Whitbourn R., Meredith I., Garcia-Garcia H. M., Veldhof S., Rapoza R. & Ormiston J. A. (20150827). Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). : JACC. Cardiovascular interventions.
Chicago
Onuma Yoshinobu, Serruys Patrick W, Muramatsu Takashi, Nakatani Shimpei, van Geuns Robert-Jan, de Bruyne Bernard, Dudek Dariusz, Christiansen Evald, Smits Pieter C, Chevalier Bernard, McClean Dougal, Koolen Jacques, Windecker Stephan, Whitbourn Robert, Meredith Ian, Garcia-Garcia Hector M, Veldhof Susan, Rapoza Richard and Ormiston John A. 20150827. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). : JACC. Cardiovascular interventions.
Harvard
Onuma Y., Serruys P. W., Muramatsu T., Nakatani S., van Geuns R., de Bruyne B., Dudek D., Christiansen E., Smits P. C., Chevalier B., McClean D., Koolen J., Windecker S., Whitbourn R., Meredith I., Garcia-Garcia H. M., Veldhof S., Rapoza R. and Ormiston J. A. (20150827). Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). : JACC. Cardiovascular interventions.
MLA
Onuma Yoshinobu, Serruys Patrick W, Muramatsu Takashi, Nakatani Shimpei, van Geuns Robert-Jan, de Bruyne Bernard, Dudek Dariusz, Christiansen Evald, Smits Pieter C, Chevalier Bernard, McClean Dougal, Koolen Jacques, Windecker Stephan, Whitbourn Robert, Meredith Ian, Garcia-Garcia Hector M, Veldhof Susan, Rapoza Richard and Ormiston John A. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). : JACC. Cardiovascular interventions. 20150827.